{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:12:07Z","timestamp":1791871927540,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270626"],"award-info":[{"award-number":["82270626"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China Mega-Project for Infectious Diseases","award":["2017ZX10203202"],"award-info":[{"award-number":["2017ZX10203202"]}]},{"name":"China Mega-Project for Infectious Diseases","award":["2013ZX10002005"],"award-info":[{"award-number":["2013ZX10002005"]}]},{"name":"Project of Beijing Science and Technology Committee","award":["Z191100007619037"],"award-info":[{"award-number":["Z191100007619037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background &amp; aims<\/jats:title>\n                <jats:p>Cirrhosis was the leading cause of morbidity and mortality in adults, but data on the burden and trends were sparse in children and adolescents. We aimed to assess the trends in 204 countries and territories over the past 30\u00a0years in children and adolescents aged 0\u201319\u00a0years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data on cirrhosis was collected by the Global Burden of Disease (GBD) 2019 database from 1990 to 2019. We reported on the number, rates, and average annual percentage changes (AAPCs) of incidence and disability-adjusted life-years (DALYs) of cirrhosis at global, regional, and national level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Globally, the incident numbers of cirrhosis in children and adolescents increased from 204,767 in 1990 to 241,364 in 2019, an increase of 17.9%, with an AAPC 0.13(0.10 to 0.16). Prevalence (AAPC\u2009=\u2009\u2212\u00a02.27[\u2212\u00a02.39 to \u2212\u00a02.15]), mortality (AAPC\u2009=\u2009\u2212\u00a01.68 [\u2212\u00a01.86 to \u2212\u00a01.5]), and DALYs rate (AAPC\u2009=\u2009\u2212\u00a01.72[\u2212\u00a01.88 to \u2212\u00a01.56]) of cirrhosis have decreased significantly. Cirrhosis incident rates varied between different ages. Cirrhosis caused by alcohol use (AAPC\u2009=\u20091[0.8 to 1.1]; incidence cases increased 48%), hepatitis C (AAPC\u2009=\u20090.4 [0.4 to 0.5]), NAFLD (AAPC\u2009=\u20090.5 [0.3 to 0.6]) have been increasing, while only hepatitis B (\u2212\u00a00.3[\u2212\u00a00.4 to \u2212\u00a00.2]) decreasing. Incidence cases of cirrhosis were increased in low (101.6%) and low-middle sociodemographic index (SDI 21.1%) areas, while decreasing in middle and above SDI areas. At the regional level, the largest increases count was observed in Sub-Saharan Africa.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Global incidence rate of cirrhosis has been increasing, while the DALYs rate has been decreasing in children and adolescents. Morbidity of cirrhosis caused by hepatitis B declined, while hepatitis C, NAFLD, and alcohol use increased.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12072-023-10531-y","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T18:03:13Z","timestamp":1682532193000},"page":"238-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Global, regional, and national burdens of cirrhosis in children and adolescents aged under 19\u00a0years from 1990 to 2019"],"prefix":"10.1007","volume":"18","author":[{"given":"Chi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0317-7536","authenticated-orcid":false,"given":"Guiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"issue":"10258","key":"10531_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9.","journal-title":"Lancet"},{"issue":"3","key":"10531_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","volume":"5","author":"GBD 2017 Cirrhosis Collaborators","year":"2020","unstructured":"GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245\u2013266. https:\/\/doi.org\/10.1016\/S2468-1253(19)30349-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10531_CR3","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"GBD 2019 Hepatitis B Collaborators","year":"2022","unstructured":"GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796\u2013829. https:\/\/doi.org\/10.1016\/S2468-1253(22)00124-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10531_CR4","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1111\/liv.15347","volume":"42","author":"N Veracruz","year":"2022","unstructured":"Veracruz N, Gish RG, Cheung R, Chitnis AS, Wong RJ. Global trends and the impact of chronic hepatitis B and C on disability-adjusted life years. Liver Int. 2022;42(10):2145\u20132153","journal-title":"Liver Int"},{"issue":"10347","key":"10531_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0140-6736(22)00847-9","volume":"400","author":"Population-level risks of alcohol consumption by amount","year":"2022","unstructured":"Population-level risks of alcohol consumption by amount. geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet (London, England). 2022;400(10347):185\u2013235","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10531_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/hep.32228","volume":"75","author":"JM Paik","year":"2022","unstructured":"Paik JM, Kabbara K, Eberly KE, Younossi Y, Henry L, Younossi ZM. Global burden of NAFLD and chronic liver disease among adolescents and young adults. Hepatology. 2022;75(5):1204\u20131217","journal-title":"Hepatology"},{"issue":"11","key":"10531_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3760\/cma.j.issn.1007-3418.2019.11.008","volume":"27","author":"Chinese Society of Hepatology","year":"2019","unstructured":"Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2019;27(11):846\u2013865. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2019.11.008. (in Chinese)","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"6","key":"10531_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S2352-4642(22)00073-6","volume":"6","author":"B Armocida","year":"2022","unstructured":"Armocida B, Monasta L, Sawyer S, et al. Burden of non-communicable diseases among adolescents aged 10\u201324 years in the EU, 1990\u20132019: a systematic analysis of the global burden of diseases study 2019. The Lancet Child Adoles Health. 2022;6(6):367\u2013383","journal-title":"The Lancet Child Adoles Health"},{"issue":"1","key":"10531_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.14309\/ajg.0000000000001564","volume":"117","author":"M Kehar","year":"2022","unstructured":"Kehar M, Griffiths R, Flemming JA. Increasing incidence of cirrhosis over the past 2 decades among children in ontario. Canada Am J Gastroenterol. 2022;117(1):189\u2013192","journal-title":"Canada Am J Gastroenterol"},{"issue":"10129","key":"10531_CR10","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/S0140-6736(18)30104-1","volume":"391","author":"Countdown to 2030 Collaboration","year":"2018","unstructured":"Countdown to 2030 Collaboration. Countdown to 2030: tracking progress towards universal coverage for reproductive, maternal, newborn, and child health. Lancet. 2018;391(10129):1538\u20131548. https:\/\/doi.org\/10.1016\/S0140-6736(18)30104-1.","journal-title":"Lancet"},{"issue":"11","key":"10531_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S2352-4642(19)30299-8","volume":"3","author":"The Lancet Child Adolescent Health","year":"2019","unstructured":"The Lancet Child Adolescent Health. Universal health coverage and the forgotten generation. Lancet Child Adolesc Health. 2019;3(11):749. https:\/\/doi.org\/10.1016\/S2352-4642(19)30299-8.","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"10531_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S2468-1253(19)30385-1","volume":"5","author":"J Schmelzer","year":"2020","unstructured":"Schmelzer J, Dugan E, Blach S, et al. Global prevalence of hepatitis C virus in children in 2018: a modelling study. Lancet Gastroenterol Hepatol. 2020;5(4):374\u2013392","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10258","key":"10531_CR13","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","volume":"396","author":"Global age-sex-specific fertility","year":"2020","unstructured":"Global age-sex-specific fertility. mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the global burden of disease study 2019. Lancet (London, England). 2020;396(10258):1160\u20131203","journal-title":"Lancet (London, England)"},{"key":"10531_CR14","unstructured":"Global burden of disease study 2019 (GBD 2019) data resources. Available from: https:\/\/ghdx.healthdata.org\/gbd-2019 [Accessed 30 Oct 2022]. 2022"},{"key":"10531_CR15","unstructured":"Disability-adjusted life years (DALYs). Available from: https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/158 [Accessed 28 Nov 2022]. 2022."},{"key":"10531_CR16","unstructured":"Older children and young adolescent mortality (5 to 14 years). Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/older-children-and-young-adolescent-mortality-%285-to-14-years%29 [Accessed 28 Nov 2022]. 2022."},{"issue":"11","key":"10531_CR17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S2352-4642(22)00219-X","volume":"6","author":"J Zhang","year":"2022","unstructured":"Zhang J, Ma B, Han X, Ding S, Li Y. Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10\u201324 years from 1990 to 2019: a trend analysis based on the global burden of disease study 2019. The Lancet Child Adolescent Health. 2022;6(11):763\u2013776","journal-title":"The Lancet Child Adolescent Health"},{"issue":"3","key":"10531_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u2013351","journal-title":"Stat Med"},{"key":"10531_CR19","unstructured":"Application for command-line (Batch\/Callable) version of joinpoint regression software. Available from: https:\/\/surveillance.cancer.gov\/joinpoint\/callable\/ [Accessed 28 Nov 2022]."},{"issue":"5","key":"10531_CR20","first-page":"403","volume":"29","author":"M Li","year":"2021","unstructured":"Li M, Su JT, Wu SS, Wei ZH, Kong YY, Jia JD. Correlation among age, sex, and liver diseases-related mortality risk in patients with hepatitis B virus-related liver cirrhosis (in Chinese). Zhonghua Gan Zang Bing Za Zhi. 2021;29(5):403\u2013408","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"6","key":"10531_CR21","first-page":"605","volume":"40","author":"J Liu","year":"2019","unstructured":"Liu J, Liu M. Progress and challenges in achieving the WHO goal on \u201cElimination of Hepatitis B by 2030\u201d in China (in Chinese). Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40(6):605\u2013609","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10531_CR22","unstructured":"Global hepatitis report, 2017. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241565455 [Accessed 4 Dec 2022]. 2017"},{"issue":"6","key":"10531_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3390\/ijerph13060604","volume":"13","author":"X Lyu","year":"2016","unstructured":"Lyu X, Liu K, Chen Y, et al. (2016) Analysis of risk factors associated with the development of hepatocellular carcinoma in chronic HBV-infected chinese: a meta-analysis. Int J Environ Res Public Health. 2016;13(6):604","journal-title":"Int J Environ Res Public Health"},{"issue":"9865","key":"10531_CR24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","volume":"381","author":"P Marcellin","year":"2013","unstructured":"Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet (London, England). 2013;381(9865):468\u2013475","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10531_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u2013238","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10531_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/apt.17096","volume":"56","author":"J Li","year":"2022","unstructured":"Li J, Ha A, Rui F, et al. Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000\u20132021. Aliment Pharmacol Ther. 2022;56(3):396\u2013406","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10531_CR27","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/hep.28123","volume":"62","author":"ZM Younossi","year":"2015","unstructured":"Younossi ZM, Otgonsuren M, Henry L, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology. 2015;62(6):1723\u20131730","journal-title":"Hepatology"},{"key":"10531_CR28","unstructured":"Adolescent and young adult health. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/adolescents-health-risks-and-solutions [Accessed 5 Dec 2022]."},{"key":"10531_CR29","unstructured":"Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. Available from: https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/EB150\/B150_7Add1-en.pdf [Accessed 5 Dec 2022]. 2022."}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10531-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-023-10531-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10531-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T04:39:15Z","timestamp":1707539955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-023-10531-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10531"],"URL":"https:\/\/doi.org\/10.1007\/s12072-023-10531-y","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"assertion":[{"value":"25 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Chi Zhang, Yiqi Liu, Hong Zhao, Guiqiang Wang declare no conflict interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The data for this study were obtained from a publicly available database and did not require ethical review or informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}